Global Tissue Plasminogen Activator Market to Surpass US$ 3,491.5 Million by 2027, Says Coherent Market Insights (CMI)

According to Coherent Market Insights, the global tissue plasminogen activator market is estimated to be valued at US$ 2,455.4 million in 2020 and is expected to exhibit a CAGR of 5.2% over the forecast period (2020-2027).

Key Trends and Analysis of the Global Tissue Plasminogen Activator Market:

Increasing number of stroke centers (hospitals centers to treat individuals who suffered from stroke) is expected to drive the growth of the global tissue plasminogen activator market. For instance, Brazilian Stroke Research Network (BSRN) report 2019, stated that the number of stroke centers increased from 35 in 2008 to 149 in 2017 and stroke mortality in public stroke centers decreased from 17.9% in 2010 to 12.8% in 2014 in Brazil.

Increasing expenditure on treatment of stroke is expected to aid in significant growth of the market over the forecast period. For instance, in 2017, the American Heart Association (AHA) recorded stroke costs as US$ 34 billion in the U.S. every year, which includes medicines for the treatment of stroke and cost of health care services.

Request for Sample copy of this report @ https://www.coherentmarketinsights.com/insight/request-sample/2469

Increasing government initiatives for the treatment of cardiac strokes with the help of various treatment methods including tissue plasminogen activators is expected to drive the market growth over the forecast period. For instance, in 2018, European Stroke Organisation (ESO), a government organization, announced the European Stroke Action Plan, a plan to address all the cardiovascular diseases from year 2018 to 2030 in European Nations. The plan includes implementing a strong medical support by establishing stroke support organisation such as acute stroke unit care in each European country. The plan also includes management/ treatment of the strokes with various treatment methods such as intravenous thrombolysis, endovascular thrombectomy(EVT), and hemicraniectomy, and use of tissue plasminogen activators (Alteplase) for treatment of acute ischemic stroke.

Key Market Takeaways:

The global tissue plasminogen activator market is expected to exhibit a CAGR of 5.2% over the forecast period. This is owing to increasing burden of cardiovascular diseases such as coronary heart diseases and others leading to conditions such as heart attacks and myocardial infarctions. For instance, according to the U.S. Department of Health & Human Services report 2018, approximately 30.3 million or 12.1% of the adults in the U.S. were diagnosed with cardiovascular diseases such as coronary artery disease, ischemic heart disease, and others in 2018, Moreover, in 2017, the American Heart Association (AHA) recorded stroke costs as US$ 34 billion in the U.S. every year, which includes medicines for the treatment of stroke and cost of health care service.

Competitive Landscape:

Key players operating in the global Tissue Plasminogen Activator Market include F. Hoffmann-La Roche AG, Boehringer Ingelheim GmbH, CHIESI Farmaceutici S.p.A., Gennova Biopharmaceuticals Ltd, Abbott Laboratories, and Reliance Life Sciences

Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/2469

Market Segmentation:

• Global Tissue Plasminogen Activator Market, By Drug Type:
  • Alteplase
  • Reteplase
  • Tenecteplase
• Global Tissue Plasminogen Activator Market, By Application:
  • Ischemic Stroke
  • Myocardial Infarction
  • Pulmonary Embolism
  • Thrombolysis
  • Others
• Global Tissue Plasminogen Activator Market, By Region:
  • North America
    • By Country
      • U.S.
      • Canada
  • Latin America
    • By Country
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • By Country
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • By Country
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • By Country
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • By Country/Region
      • South Africa
      • Central Africa
      • North Africa

Related Market Intelligence Reports:

Tissue and Organ Transplantation Market, by Product Type (Tissue Products, Preservation Solution, and Immunosuppressive Drugs), by Application (Organ Transplantation and Tissue Transplantation), by End User (Hospital, Transplant Centers, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

Read more: https://www.coherentmarketinsights.com/market-insight/tissue-and-organ-transplantation-market-4342

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. Our client base includes players from across various business verticals in over 57 countries worldwide.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210510005318/en/

Global Tissue Plasminogen activator market is projected to grow at a CAGR of 5.2% during the forecast 2020-2027, Says Coherent Market Insights